BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20923118)

  • 21. Biology of Pseudomonas aeruginosa in relation to pulmonary infection in cystic fibrosis.
    Pitt TL
    J R Soc Med; 1986; 79 Suppl 12(Suppl 12):13-8. PubMed ID: 2425090
    [No Abstract]   [Full Text] [Related]  

  • 22. The salicylidene acylhydrazide INP0341 attenuates Pseudomonas aeruginosa virulence in vitro and in vivo.
    Uusitalo P; Hägglund U; Rhöös E; Scherman Norberg H; Elofsson M; Sundin C
    J Antibiot (Tokyo); 2017 Aug; 70(9):937-943. PubMed ID: 28588224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pseudomonas aeruginosa exotoxin A and keratitis in mice.
    Pillar CM; Hobden JA
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1437-44. PubMed ID: 11980858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Extracellular enzymes of Pseudomonas aeruginosa as virulence factors].
    Jaeger KE
    Immun Infekt; 1994 Oct; 22(5):177-80. PubMed ID: 7982713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of exoenzyme S to the virulence of Pseudomonas aeruginosa.
    Nicas TI; Iglewski BH
    Antibiot Chemother (1971); 1985; 36():40-8. PubMed ID: 2988426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Common virulence factors for bacterial pathogenicity in plants and animals.
    Rahme LG; Stevens EJ; Wolfort SF; Shao J; Tompkins RG; Ausubel FM
    Science; 1995 Jun; 268(5219):1899-902. PubMed ID: 7604262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal studies of virulence factors of Pseudomonas aeruginosa in cystic fibrosis.
    Burke V; Robinson JO; Richardson CJ; Bundell CS
    Pathology; 1991 Apr; 23(2):145-8. PubMed ID: 1745565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteolytic cleavage of exotoxin A from Pseudomonas aeruginosa: formation of an ADP-ribosyltransferase active fragment by the action of Pseudomonas elastase.
    Sanai Y; Morihara K; Tsuzuki H; Homma JY; Kato I
    FEBS Lett; 1980 Oct; 120(1):131-4. PubMed ID: 6254804
    [No Abstract]   [Full Text] [Related]  

  • 29. Production of elastase and other exoproducts by environmental isolates of Pseudomonas aeruginosa.
    Nicas TI; Iglewski BH
    J Clin Microbiol; 1986 May; 23(5):967-9. PubMed ID: 3086372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The frequency of genes encoding exotoxin A and exoenzyme S in Pseudomonas aeruginosa strains isolated from burn patients.
    Khosravi AD; Shafie F; Abbasi Montazeri E; Rostami S
    Burns; 2016 Aug; 42(5):1116-1120. PubMed ID: 27263417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pseudomonas aeruginosa: biology, mechanisms of virulence, epidemiology.
    Vasil ML
    J Pediatr; 1986 May; 108(5 Pt 2):800-5. PubMed ID: 3009772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new regulator of pathogenicity (bvlR) is required for full virulence and tight microcolony formation in Pseudomonas aeruginosa.
    McCarthy RR; Mooij MJ; Reen FJ; Lesouhaitier O; O'Gara F
    Microbiology (Reading); 2014 Jul; 160(Pt 7):1488-1500. PubMed ID: 24829363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is Pseudomonas aeruginosa exotoxin A a good carrier protein for conjugate vaccines?
    Pier GB
    Hum Vaccin; 2007; 3(2):39-40; author reply 41. PubMed ID: 17268204
    [No Abstract]   [Full Text] [Related]  

  • 34. Pseudomonas aeruginosa cystic fibrosis clinical isolates produce exotoxin A with altered ADP-ribosyltransferase activity and cytotoxicity.
    Gallant CV; Raivio TL; Olson JC; Woods DE; Storey DG
    Microbiology (Reading); 2000 Aug; 146 ( Pt 8)():1891-1899. PubMed ID: 10931893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple roles of the pilus biogenesis protein pilD: involvement of pilD in excretion of enzymes from Pseudomonas aeruginosa.
    Strom MS; Nunn D; Lory S
    J Bacteriol; 1991 Feb; 173(3):1175-80. PubMed ID: 1671384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudomonas aeruginosa exoproducts as pulmonary virulence factors.
    Cash HA; Straus DC; Bass JA
    Can J Microbiol; 1983 Apr; 29(4):448-56. PubMed ID: 6406026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP). Application in patients with diffuse panbronchiolitis.
    Homma JY; Tanimoto H
    Antibiot Chemother (1971); 1987; 39():215-21. PubMed ID: 3118783
    [No Abstract]   [Full Text] [Related]  

  • 38. Exotoxin A from various Pseudomonas aeruginosa cultures: in vitro activity measured by enzyme-linked immunosorbent assay (ELISA).
    Ogaard AR; Cryz SJ; Berdal BP
    Acta Pathol Microbiol Immunol Scand B; 1985 Jun; 93(3):217-23. PubMed ID: 3929560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of Pseudomonas aeruginosa virulence factors from clinical and environmental isolates with pathogenicity in the neutropenic mouse.
    Woods DE; Lam JS; Paranchych W; Speert DP; Campbell M; Godfrey AJ
    Can J Microbiol; 1997 Jun; 43(6):541-51. PubMed ID: 9226874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenetic factors of Pseudomonas aeruginosa.
    Bergan T
    Scand J Infect Dis Suppl; 1981; 29():7-12. PubMed ID: 6797059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.